Risk of internal malignancies, cutaneous malignant melanoma and non‐melanoma skin cancer among patients with vitiligo: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Risk of internal malignancies, cutaneous malignant melanoma and non‐melanoma skin cancer among patients with vitiligo: a systematic review and meta‐analysis

Published:2022-06-17 Issue:10 Volume:36 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Long V.S.¹^ORCID,Law Y.X.T.²,Yew Y.W.³,Choi C.‐E.E.¹^ORCID

Affiliation:

1. Division of Dermatology, Department of Medicine National University Healthcare System Singapore Singapore

2. Department of Urology, National University Hospital National University Healthcare System Singapore Singapore

3. Medical Department National Skin Cancer Singapore Singapore

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18310

Reference5 articles.

1. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

2. Hazard rate ratio and prospective epidemiological studies

3. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012

4. The dark side of the light: mechanisms of photocarcinogenesis

5. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Le ruxolitinib (Opzelura®), une crème pour repigmenter le vitiligo;Actualités Pharmaceutiques;2024-09

2. Risk of thyroid cancer among patients with vitiligo: A systematic review and meta-analysis;Dermatologica Sinica;2023

3. Quoi de neuf en dermatologie clinique ?;Annales de Dermatologie et de Vénéréologie - FMC;2022-12